CME Group Inc. (CME) Revenue History
Annual and quarterly revenue from 2000 to present
CME Revenue Over Time (2000–2025)
CME Revenue Growth History
23 of 25 years with positive growth- FY2000 revenue growth
- N/A
- FY2001 revenue growth
- +75.1%
- FY2002 revenue growth
- +18.3%
- FY2003 revenue growth
- +14.3%
- FY2004 revenue growth
- +34.6%
- FY2005 revenue growth
- +23.3%
- FY2006 revenue growth
- +22.5%
- FY2007 revenue growth
- +61.1%
- FY2008 revenue growth
- +45.8%
- FY2009 revenue growth
- +2.0%
- FY2010 revenue growth
- +15.0%
- FY2011 revenue growth
- +9.2%
- FY2012 revenue growth
- -11.2%
- FY2013 revenue growth
- +0.7%
- FY2014 revenue growth
- +6.0%
- FY2015 revenue growth
- +6.9%
- FY2016 revenue growth
- +8.1%
- FY2017 revenue growth
- +1.4%
- FY2018 revenue growth
- +18.2%
- FY2019 revenue growth
- +13.0%
- FY2020 revenue growth
- +0.3%
- FY2021 revenue growth
- -4.0%
- FY2022 revenue growth
- +7.0%
- FY2023 revenue growth
- +11.1%
- FY2024 revenue growth
- +9.9%
- FY2025 revenue growth
- +6.4%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $1.88B | — |
| Q4 2025 | $1.65B | — |
| Q3 2025 | $1.54B | — |
| Q2 2025 | $1.69B | — |
| Q1 2025 | $1.64B | — |
| Q4 2024 | $1.53B | — |
| Q3 2024 | $1.58B | — |
| Q2 2024 | $1.53B | — |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
CME's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
CME Revenue Analysis (2000–2025)
Current Revenue & Growth
As of June 21, 2026, CME Group Inc. (CME) generated trailing twelve-month (TTM) revenue of $6.76 billion, reflecting strong growth of +14.5% year-over-year. The most recent quarter (Q1 2026) recorded $1.88 billion in revenue, up 14.0% sequentially.
Historical Growth Trajectory
CME's 5-year compound annual growth rate (CAGR) stands at +6.0%, indicating steady revenue expansion. The 3-year CAGR of +9.1% exceeds the 5-year average, indicating an acceleration in the most recent period. CME Group Inc.'s highest annual revenue of $6.52 billion was recorded in 2025, an all-time high.
Revenue by Segment
CME's revenue is primarily driven by clearing and transaction fees (81%), MarketData (12%), and OtherRevenue (7%). With over half of revenue concentrated in clearing and transaction fees, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Financial Services sector peers — including ICE, CBOE, and NDAQ. Compare CME vs ICE →
CME Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CMECurrent | $6.8B | +14.5% | +6.0% | 64.9% | |
 ICE | $12.6B | - | - | 38.7% | |
 CBOE | $4.7B | - | - | 32.1% | |
 NDAQ | $8.2B | - | - | 28.4% | |
 MKTX | $849M | - | - | 41.2% | |
 MSCI | $3.1B | - | - | 54.7% |
CME Historical Revenue Data (2000–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $6.52B | - | $5.61B | 86.1% | $4.23B | 64.9% |
| 2024 | $6.13B | - | $5.28B | 86.1% | $3.93B | 64.1% |
| 2023 | $5.58B | - | $4.75B | 85.1% | $3.44B | 61.6% |
| 2022 | $5.02B | - | $4.27B | 85.0% | $3.02B | 60.1% |
| 2021 | $4.69B | - | $3.85B | 82.2% | $2.65B | 56.4% |
| 2020 | $4.88B | - | $4.03B | 82.5% | $2.64B | 54.0% |
| 2019 | $4.87B | - | $3.97B | 81.5% | $2.59B | 53.2% |
| 2018 | $4.31B | - | $3.64B | 84.4% | $2.61B | 60.5% |
| 2017 | $3.64B | - | $3.08B | 84.5% | $2.31B | 63.4% |
| 2016 | $3.60B | - | $3.05B | 84.9% | $2.20B | 61.2% |
| 2015 | $3.33B | - | $2.75B | 82.5% | $1.99B | 59.8% |
| 2014 | $3.11B | - | $2.53B | 81.2% | $1.77B | 56.8% |
| 2013 | $2.94B | - | $2.38B | 81.1% | $1.64B | 55.8% |
| 2012 | $2.91B | - | $2.38B | 81.6% | $1.69B | 58.1% |
| 2011 | $3.28B | - | $2.76B | 84.2% | $2.02B | 61.6% |
Full Stock Analysis
Deep dive into CME consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
26+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CME — Frequently Asked Questions
Quick answers to the most common questions about buying CME stock.
Is CME's revenue growth accelerating or slowing?
CME revenue growth is holding steady at +14.5% year-over-year. TTM revenue is $6.8B. The current growth rate closely tracks the 5-year CAGR of +6.0%, signalling consistent execution.
What is CME's revenue history from 2000 to 2026?
CME Group Inc. (CME) revenue history spans 2000 to 2026. TTM revenue as of 2026 is $6.8B, growing at +14.5% YoY. The 5-year CAGR is +6.0%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is CME's long-term revenue growth rate (CAGR)?
CME Group Inc.'s 5-year revenue CAGR of +6.0% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +14.5% is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for CME.
Why does CME's quarterly revenue fluctuate?
CME quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. CME Group Inc.'s revenue data from 2000 to 2026 shows full historical quarterly detail on this page.
How is CME's revenue distributed by segment?
CME reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does CME's revenue compare to industry peers?
CME Group Inc. (CME) with TTM revenue of $6.8B and +14.5% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.